Contact us : info@bioworlde.com
Home > Product > Primary Antibodies
IGFBP2 polyclonal antibody BS90689
  • Western blot analysis of IGFBP2 on Human serum (1) and NCCIT (2) lysates using anti-IGFBP2 antibody at 1/500 dilution.
  • Immunohistochemical analysis of paraffin-embedded human liver tissue using anti-IGFBP2 antibody. Counter stained with hematoxylin.
Product NameIGFBP2 polyclonal antibody
Catalog No.BS90689
Swiss-ProtP18065(Human)
Host Rabbit
ReactivityHuman
ApplicationsWB IHC
Application_allWB:1:500-1:2,000 IHC:1:50-1:200
BiowMW35 kDa
Alternative NameIBP-2, IGF-binding protein 2, IGFBP-2, IGFBP2, BP2, IBP2, BP 2, BP2, IBP 2, IBP-2, IBP2, IBP2, IGF binding protein 2, IGF BP53, IGF-binding protein 2, IGFBP 2, IGFBP-2, IGFBP2, IGFBP53, Insulin like growth factor binding protein 2 36kDa, Insulin like growth factor binding protein 2, Insulin like growth factor-binding protein 2 precursor, Insulin-like growth factor-binding protein 2,
Purification&PurityProA affinity purified
ConjugateUnconjugated
ModificationUnmodification
Browse similar products>>
Size Price
50ul $258
100ul $398
Add to cart My orders
Product Name :
IGFBP2 polyclonal antibody
Background :
The Insulin-like growth factor-binding proteins (IGFBPs), a family of homologous proteins that have co-evolved with the IGFs, serve not only as shuttle molecules for the soluble IGFs, but also confer a level of regulation to the IGF signaling system. Physical association of the IGFBPs with IGF influences the bio-availability of the growth factors, and their concentration and distribution in the extracellular environment. The IGFBPs also appear to have biological activity independent of the IGFs. Seven IGFBPs have been described, each differing in their tissue distribution, half-lives and modulation of IGF interactions with their receptors. IGFBP1 is negatively regulated by Insulin production. The IGFBP1 gene is expressed at a high level during fetal liver development and in response to nutritional changes and diabetes. IGFBP2, which may function as a chaperone, escorting IGFs to their target tissues, is expressed in several human tissues including fetal eye and fetal brain.
Product :
Rabbit IgG, 1mg/ml in PBS with 0.02% sodium azide, 50% glycerol, pH7.2
Storage&Stability :
Store at +4°C after thawing. Aliquot store at -20°C or -80°C. Avoid repeated freeze / thaw cycles.
Specificity :
IGFBP2 polyclonal antibody detects endogenous levels of IGFBP2 protein.
Immunogen :
Recombinant protein
Conjugate :
Unconjugated
Modification :
Unmodification
  • Western blot analysis of IGFBP2 on Human serum (1) and NCCIT (2) lysates using anti-IGFBP2 antibody at 1/500 dilution.
  • Immunohistochemical analysis of paraffin-embedded human liver tissue using anti-IGFBP2 antibody. Counter stained with hematoxylin.
Bioworld Biotech only provide peptides for our antibodies and do not provide additional peptide customization services.

Price/Size :

USD 368/1mg/vial



Tips: 

For phospho antibody, we provide phospho peptide(0.5mg) and non-phospho peptide(0.5mg).

Describe :

Blocking peptides are peptides that bind specifically to the target antibody and block antibody binding. These peptide usually contains the epitope recognized by the antibody. Antibodies bound to the blocking peptide no longer bind to the epitope on the target protein. This mechanism is useful when non-specific binding is an issue, for example, in Western blotting (WB) and Immunohistochemistry (IHC). By comparing the staining from the blocked antibody versus the antibody alone, one can see which staining is specific; Specific binding will be absent from the western blot or IHC performed with the neutralized antibody.

Formula:

Synthetic peptide was lyophilized with 100% acetonitrile and is supplied as a powder. Reconstitute with 0.1 ml DI water for a final concentration of 10 mg/ml.The purity is >90%,tested by HPLC and MS.

Storage:

The freeze-dried powder is more stable. For short time at 2-8°C. For long term storage store at -20°C. 


Note :

This product is for research use only (RUO only). Not for use in diagnostic or therapeutic procedures.
COPYRIGHT © 2015-2018 Bioworld Technology, Inc. All rights reserved POLYCLONAL AND MONOCLONAL ANTIBODY CENTER